GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (FRA:5IU) » Definitions » Cash Flow for Lease Financing

Isofol Medical AB (FRA:5IU) Cash Flow for Lease Financing : €-0.04 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Isofol Medical AB Cash Flow for Lease Financing?

Isofol Medical AB's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was €0.00 Mil. Isofol Medical AB's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.04 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2023 ), Isofol Medical AB's Cash Flow for Lease Financing remained the same in Mar. 2024 (€0.00 Mil).

Isofol Medical AB Cash Flow for Lease Financing Historical Data

The historical data trend for Isofol Medical AB's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Cash Flow for Lease Financing Chart

Isofol Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only -0.12 -0.15 -0.15 -0.16 -

Isofol Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.03 -0.01 - -

Isofol Medical AB Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isofol Medical AB Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Isofol Medical AB (FRA:5IU) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (FRA:5IU) » Definitions » Cash Flow for Lease Financing
Comparable Companies
OSTO:SPRINT OSTO:ELIC OSTO:ALZ OSTO:BIOVIC B OSTO:NXTCL XSAT:CESSA OSTO:ACE OSTO:LIPUM OSTO:SIMRIS B OSTO:ZICC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ISOFOL:Sweden
Address
Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46
Website
http://www.isofol.se
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (FRA:5IU) Headlines

No Headlines